Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $14.87 $19.38 Friday, 10th May 2024 RGNX stock ended at $15.44. This is 1.53% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 10.42% from a day low at $14.87 to a day high of $16.42.
90 days $14.87 $28.80
52 weeks $11.83 $28.80

Historical REGENXBIO Inc. prices

Date Open High Low Close Volume
Jan 24, 2024 $14.41 $14.50 $13.93 $13.99 281 496
Jan 23, 2024 $14.47 $15.08 $14.06 $14.19 316 024
Jan 22, 2024 $13.68 $14.20 $13.51 $14.20 440 082
Jan 19, 2024 $13.79 $13.88 $13.45 $13.71 312 006
Jan 18, 2024 $14.17 $14.19 $13.68 $13.77 367 483
Jan 17, 2024 $15.25 $15.25 $13.99 $14.16 482 303
Jan 16, 2024 $14.97 $15.94 $14.63 $15.27 868 927
Jan 12, 2024 $14.80 $15.38 $14.75 $15.13 447 861
Jan 11, 2024 $14.66 $14.88 $14.17 $14.57 550 233
Jan 10, 2024 $14.60 $15.00 $14.44 $14.87 527 639
Jan 09, 2024 $14.24 $14.85 $13.90 $14.67 804 643
Jan 08, 2024 $16.03 $16.03 $12.76 $14.44 1 729 861
Jan 05, 2024 $17.10 $17.67 $16.44 $16.45 475 786
Jan 04, 2024 $17.34 $17.69 $17.02 $17.40 536 424
Jan 03, 2024 $18.38 $18.38 $17.03 $17.30 471 298
Jan 02, 2024 $17.76 $18.69 $17.65 $18.34 287 539
Dec 29, 2023 $18.54 $18.54 $17.73 $17.95 531 657
Dec 28, 2023 $18.89 $19.01 $18.07 $18.54 441 921
Dec 27, 2023 $18.78 $19.09 $18.29 $18.87 334 660
Dec 26, 2023 $18.90 $19.15 $18.70 $18.75 288 790
Dec 22, 2023 $18.71 $19.21 $18.16 $18.62 633 738
Dec 21, 2023 $18.60 $19.03 $18.40 $18.45 387 646
Dec 20, 2023 $19.55 $19.55 $18.25 $18.30 534 730
Dec 19, 2023 $19.77 $20.19 $19.18 $19.61 371 958
Dec 18, 2023 $20.11 $20.27 $19.44 $19.51 326 885
Click to get the best stock tips daily for free!

About REGENXBIO Inc.

REGENXBIO. REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's lead product candidate is RGX-314, wh... RGNX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT